Compounds > cy 208-243
Page last updated: 2024-08-24

cy 208-243 and MPTP Neurotoxicity Syndrome

cy 208-243 has been researched along with MPTP Neurotoxicity Syndrome in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guillén, J; Laguna, J; Luquin, MR; Martínez-Lage, JM; Martínez-Vila, E1
Bédard, PJ; Di Paolo, T; Gagnon, C; Gomez-Mancilla, B; Markstein, R1
Cruz Rodriguez, M; Del Rio, L; Dominguez, J; Guillén, J; Legarda, I; Luquin, MR; Martínez-Lage, JM1
Bedard, PJ; Blanchet, P; Chen, JS; Doucet, JP; Grondin, R; Hope, BT; Iadarola, MJ; Jasmin, BJ; Nakabeppu, Y; Nestler, EJ; Robertson, GS; St-Jean, M; Wigle, N1
Bédard, PJ; Gomez-Mancilla, B1

Other Studies

5 other study(ies) available for cy 208-243 and MPTP Neurotoxicity Syndrome

ArticleYear
Functional interaction between dopamine D1 and D2 receptors in 'MPTP' monkeys.
    European journal of pharmacology, 1994, Mar-03, Volume: 253, Issue:3

    Topics: Animals; Benzazepines; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Indoles; Macaca fascicularis; Male; Motor Activity; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Phenanthridines; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride

1994
Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptors.
    Progress in neuro-psychopharmacology & biological psychiatry, 1995, Volume: 19, Issue:4

    Topics: Animals; Autoradiography; Behavior, Animal; Brain Chemistry; Bromocriptine; Dopamine Agents; Dopamine Agonists; Female; Indoles; Macaca fascicularis; MPTP Poisoning; Neostriatum; Ovariectomy; Parkinson Disease, Secondary; Phenanthridines; Receptors, Dopamine D1; Receptors, Dopamine D2

1995
Pulsatile administration of D1 but not D2 dopamine agonists induces behavioral tolerance in MPTP-treated monkeys.
    Advances in neurology, 1996, Volume: 69

    Topics: Animals; Antiparkinson Agents; Behavior, Animal; Dopamine Agents; Dopamine Agonists; Drug Tolerance; Female; Indoles; Macaca fascicularis; Male; Movement; MPTP Poisoning; Oxazines; Phenanthridines; Receptors, Dopamine D1; Receptors, Dopamine D2

1996
Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    The European journal of neuroscience, 1996, Volume: 8, Issue:2

    Topics: Animals; Bacterial Proteins; Base Sequence; Benzazepines; Blotting, Western; Cabergoline; Corpus Striatum; Denervation; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Female; Gene Expression Regulation; Genes, fos; Haloperidol; Indoles; Macaca fascicularis; Male; Molecular Weight; MPTP Poisoning; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Phenanthridines; Polymerase Chain Reaction; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, Dopamine D1; RNA, Messenger; Species Specificity; Time Factors; Transcription Factors

1996
Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys.
    Experimental neurology, 1992, Volume: 117, Issue:2

    Topics: Animals; Antiparkinson Agents; Dopamine Agents; Female; Indoles; Macaca fascicularis; Motor Activity; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Phenanthridines; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2

1992